Redox Biology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-05-02 陈述来自浙江省

各位大佬，with editor一般要多久啊？5天了还是这样

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2022-08-22 ms3000000882461486

这个杂志文章质量不咋样，据说有关系超级好发

4 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2022-09-22 ms7000002096877782

审稿速度:1.0 | 投稿命中率:5.0
经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript.

75 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2021-12-27 msSSSSSD

投nature需要什么准备？

77 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-01-12 ms9000001277141354 来自北京

请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！

37 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2022-10-14 tiancaiwxb

审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8
偏重的研究方向：氧化还原
经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。

56 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-04-26 14687c4em08暂无昵称来自湖南省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿#期刊论坛#

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-04-26 14687c4em08暂无昵称来自湖南省

偏重的研究方向：氧化应激;衰老， ROS
经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿#期刊论坛#

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-04-24 14687c4em08暂无昵称来自湖南省

偏重的研究方向：衰老， ROS
经验分享：已经两个半月了，一审还没回来，这速度真慢啊

38 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2129707, encodeId=88202129e071d, content=各位大佬，with editor一般要多久啊？5天了还是这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epS9bXfsQ9F45LRdNKKXSR3SceNj6EksI6D68yHJw3icDBH7OdtHgMsJZibhtxdrxsicRhanL2RGJv3Q/132, createdBy=968c2354707, createdName=陈述, createdTime=Tue May 02 15:12:02 CST 2023, time=2023-05-02, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1240213, encodeId=0279124021363, content=这个杂志文章质量不咋样，据说有关系超级好发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36116393444, createdName=ms3000000882461486, createdTime=Mon Aug 22 06:10:28 CST 2022, time=2022-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089677, encodeId=754620896e704, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：杂志效率很高编辑可以随便选因为我选的编辑和最后处理我稿件的不是同一个。但是不好投三个审稿人返了四十多个很专业意见（而且感觉不同审稿人是针对你文章不同角度）需要补充大量实验。最后想问下所有送审后拒稿的话都会建议重投吗？下面这个是套话模版么？还是可以理解为大修？ The journal office will try - but cannot guarantee - that the manuscript is handled by the same editor and reviewed by the same scientists. For your information and guidance, any specific comments explaining why I have reached this decision and those received from reviewers (if available) are listed at the end of this letter. Redox Biology values your contribution and I look forward to receiving your revised and resubmitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eadd6582344, createdName=ms7000002096877782, createdTime=Thu Sep 22 06:48:22 CST 2022, time=2022-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106295, encodeId=7f171106295bc, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109973, encodeId=7de521099e3b1, content=请问各位战友们，这个杂志需要上传全部的原始数据嘛，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=193e8504124, createdName=ms9000001277141354, createdTime=Thu Jan 12 16:46:43 CST 2023, time=2023-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2093849, encodeId=ea4720938491c, content=审稿速度:1.0 | 投稿命中率:25.0 | 影响因子:10.8 偏重的研究方向：氧化还原 经验分享：说说我的经历，我是八月初投稿，27号回来审稿意见，两个审稿人，一个比较认可，一个中性，编辑是wang hong，给了拒稿重投。九月中旬重投，编辑又邀请了两个新的审稿人，不过比较nice的是他们是在已有审稿意见的基础上进行评论，还是很人性化的。第二次投编辑给了小修，修回去没几天就接受了。客观的话，这个杂志审稿速度非常快，二十几天一般就会有结果，还是很靠谱的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c82110268, createdName=tiancaiwxb, createdTime=Fri Oct 14 22:38:50 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128559, encodeId=bd0621285597d, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:32 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128558, encodeId=82182128558f3, content=偏重的研究方向：氧化应激;衰老， ROS 经验分享：已经初审两个多月了，还是under review？是咋回事啊，我看别人的初审都很快啊，要不要催稿<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Wed Apr 26 23:59:03 CST 2023, time=2023-04-26, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2128048, encodeId=469e21280486e, content=偏重的研究方向：衰老， ROS 经验分享：已经两个半月了，一审还没回来，这速度真慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71165146050, createdName=14687c4em08暂无昵称, createdTime=Mon Apr 24 14:31:28 CST 2023, time=2023-04-24, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2121249, encodeId=b73c212124932, content=请问这个期刊综述接受率高么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76d45283648, createdName=1484acb7m09(暂无昵称), createdTime=Thu Mar 23 01:58:49 CST 2023, time=2023-03-23, status=1, ipAttribution=上海)]

2023-03-23 1484acb7m09(暂无昵称) 来自上海

请问这个期刊综述接受率高么？

33 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务